Oncology

Oncology

Biology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
1-20 of 58 ARTICLES
Featured Article
https://doi.org/10.12688/f1000research.73054.3
Research Article metrics
Revised
The association between FOXO3a rs4946936 gene polymorphism and the levels of FOXO3a among chronic granulocytic leukemia patients treated with imatinib mesylate
[version 3; peer review: 2 approved]
Peer Reviewers Invited
LATEST VERSION PUBLISHED 11 Apr 2022
https://doi.org/10.12688/f1000research.166556.1
Research Article metrics AWAITING PEER REVIEW
Detection Rate of Human Papilloma Virus Genotype 16 / 18 infections in Brain Tissues from a group of Iraqi Patients with Glioblastoma Multiforme: An In Situ Hybridization Study.
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • none
PUBLISHED 03 Sep 2025
https://doi.org/10.12688/f1000research.169080.1
Research Article metrics AWAITING PEER REVIEW
Beyond Scars: Development and Validation of a Four-Dimensional Body Image Score for Women with Breast and Gynecological Cancers - A Tunisian Multicenter Study
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 03 Sep 2025
https://doi.org/10.12688/f1000research.168812.1
Research Article metrics AWAITING PEER REVIEW
A Comparison Between Treatment Response of Chronic Myeloid Leukemia Patients Receving Imatinib or Nilotinib
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 01 Sep 2025
https://doi.org/10.12688/f1000research.164225.1
Study Protocol metrics AWAITING PEER REVIEW
QUEST: Quality of Life and Evaluation of Survival in Treatment of Bladder Cancer – A Prospective Study on Quality of Life and Survival of Bladder Cancer Patients Using Patient-Reported Outcome Measurements (PROMs)
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 29 Aug 2025
https://doi.org/10.12688/f1000research.146982.2
Research Article metrics
Revised
High Levels of Soluble P-selectin, Neutrophil Extracellular Traps, and Myeloperoxidase as Risk Factor of Deep Vein Thrombosis in Malignancy Patients Receiving Platinum-Based Chemotherapy
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Eko Adhi Pangarsa; Irawan Cosphiadi; Shinta Wardani
LATEST VERSION PUBLISHED 17 Jul 2025
https://doi.org/10.12688/f1000research.130172.4
Research Article metrics
Revised
Promising effect of cisplatin and melatonin combination on the inhibition of cisplatin resistance in ovarian cancer
[version 4; peer review: 1 approved, 3 not approved]
Peer Reviewers Seyed Mostafa Mir; Tharcisio C. Tortelli; Pavel Souček; Karin Rodland
LATEST VERSION PUBLISHED 06 Jun 2025
https://doi.org/10.12688/f1000research.164410.1
Case Report metrics AWAITING PEER REVIEW
Case Report: Pure Encapsulated Papillary Carcinoma of the Breast in a Centenarian: A Case Report of Distant Metastasis After Surgery, and review of literature
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
PUBLISHED 02 Jun 2025
https://doi.org/10.12688/f1000research.130876.2
Research Article metrics
Revised
Diagnostic utility of mast cell analysis in hypoplastic bone marrows for differentiation of aplastic anaemia from hypoplastic myelodysplastic neoplasm: A retrospective study
[version 2; peer review: 3 not approved]
Peer Reviewers Dijiong Wu; Valentina Giudice; Tsewang Tashi
LATEST VERSION PUBLISHED 14 Apr 2025
https://doi.org/10.12688/f1000research.159602.1
Case Report metrics
Case Report: Solitary fibrous tumor of the eyelid in a child: a case report and review of the literature
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Ahmet Kaan Gündüz
  • Funder
  • Hyderabad Eye Research Foundation
PUBLISHED 17 Mar 2025
https://doi.org/10.12688/f1000research.110080.6
Research Article metrics
Revised
Effects of non-contact electric fields on the kidneys and livers of tumour-bearing rats
[version 6; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Chandran Nadarajan; 162086; Tejaswi Worlikar; Mohamed Hisham Fouad Aref
  • Funder
  • Ctech Labs Edwar Technology
LATEST VERSION PUBLISHED 11 Feb 2025
https://doi.org/10.12688/f1000research.143642.5
Research Article metrics
Revised
Metabolomic characterization of human glioblastomas and patient plasma: a pilot study
[version 5; peer review: 2 approved]
Peer Reviewers Joseph Chen; Andrew J Scott
  • Funders
  • Career development award from the Dean’s Office of the UC Davis School of Medicine
  • National Cancer Institute
  • Academic Senate Large Grant
LATEST VERSION PUBLISHED 19 Sep 2024
https://doi.org/10.12688/f1000research.132524.2
Research Article metrics
Revised
Proteomics analysis of carcinogenesis in a rat model of mammary cancer induced by DMBA (7,12-dimethylbenz[a]anthracene)
[version 2; peer review: 3 approved]
Peer Reviewers Muhammad Luqman Nordin; Hevi Wihadmadyatami; Jasni Bin Sabri
  • Funder
  • Universitas Brawijaya
LATEST VERSION PUBLISHED 05 Aug 2024
https://doi.org/10.12688/f1000research.131013.2
Research Article metrics
Revised
Unraveling the molecular mechanism of novel leukemia mutations on NTRK2 (A203T & R458G) and NTRK3 (E176D & L449F) genes using molecular dynamics simulations approach
[version 2; peer review: 3 approved]
Peer Reviewers Dicson Sheeja Malar; Gurudeeban Selvaraj; Rajasekaran R.
  • Funder
  • This work was primarily supported by grants from the Deanship of Scientific Research, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
LATEST VERSION PUBLISHED 18 Jun 2024
https://doi.org/10.12688/f1000research.134992.3
Systematic Review metrics
Revised
Association between eNOS rs1799983 (894G>T) Polymorphism with Cancer and Stroke Risk: A meta-analysis
[version 3; peer review: 1 approved with reservations, 3 not approved]
Peer Reviewers Eric Tzyy Jiann Chong; Katrina Miranda; Mirza Saqib Baig; Saori Furuta
  • Funder
  • Lembaga Penelitian dan Inovasi Universitas Airlangga
LATEST VERSION PUBLISHED 10 Jun 2024
https://doi.org/10.12688/f1000research.132627.3
Research Article metrics
Revised
Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma
[version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
Peer Reviewers Griffith D Parks; Estanislao Nistal-Villan and Vicent Tur-Planells; Thomas C. N. Leung; Monica Martinez Pacheco
  • Funders
  • Rosetrees Trust
  • Neuroblastoma UK
  • Medical Research Council
  • Children's Cancer and Leukaemia Group
  • Wessex Medical Research
LATEST VERSION PUBLISHED 21 May 2024
https://doi.org/10.12688/f1000research.126721.2
Research Article metrics
Revised
Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Mattia Lauriola; Ritu Pandey and Daruka Mahadevan; Akila Prashant and Deepthi V
LATEST VERSION PUBLISHED 04 Apr 2024
https://doi.org/10.12688/f1000research.125877.2
Research Article metrics
Revised
General anaesthetics reduce acute lymphoblastic leukaemia malignancies in vitro and in vivo via CXCR4 and osteopontin mediated mechanisms
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Koichi Yuki; Paul M Maciocia and Jongwon Yoon; Victor H. Villar Cortes
  • Funders
  • Cancer Research UK
  • UK and European Research Council
  • Royal College of Anaesthetists
LATEST VERSION PUBLISHED 12 Feb 2024
https://doi.org/10.12688/f1000research.110072.4
Research Article metrics
Revised
In silico comparison between the mutated and wild-type androgen receptors and their influence on the selection of optimum androgenic receptor blockers for the treatment of prostate cancer
[version 4; peer review: 3 approved]
Peer Reviewers Zarrin Basharat; Ahmed A J Mahmood; Mahmoud A. Al-Sha'er
  • Funder
  • The author(s) declared that no grants were involved in supporting this work.
LATEST VERSION PUBLISHED 11 Jan 2024
https://doi.org/10.12688/f1000research.136362.1
Research Article metrics AWAITING PEER REVIEW
Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Universiti Brunei Darussalam
PUBLISHED 30 Nov 2023
https://doi.org/10.12688/f1000research.131688.1
Review metrics
Targeting KRAS mutation in gastrointestinal cancers
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Maria Diab; Jing Lu
  • Funder
  • National Institutes of Health
PUBLISHED 13 Nov 2023
1-20 of 58 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.